ArticlePhotoacoustics2025
High resolution photoacoustic vascular image reconstruction through the fast residual dense generative adversarial network.
Article in Photoacoustics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- In Vivo Monitoring of Pressure Ulcer Model Development and Recoverability Under Multimodal Parameters Within a Unified Field of View.Journal of biophotonics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Photoacoustic imaging is a powerful technique that provides high-resolution, deep tissue imaging. However, the time-intensive nature of photoacoustic microscopy (PAM) poses a significant challenge, especially when high-resolution images are required for real-time applications. In this study, we proposed an optimized Fast Residual Dense Generative Adversarial Network (FRDGAN) for high-quality PAM reconstruction. Through dataset validation on mouse ear vasculature, FRDGAN demonstrated superior performance in image quality, background noise suppression, and computational efficiency across multiple down-sampling scales (×4, ×8) compared to classical methods. Furthermore, in the in vivo experiments of mouse cerebral vasculature, FRDGAN achieves the improvement of 2.24 dB and 0.0255 in peak signal-to-noise ratio and structural similarity metrics in contrast to SRGAN, respectively. Our FRDGAN method provides a promising solution for fast, high-quality PAM microvascular imaging in biomedical research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.